BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2895350)

  • 1. Will antibody-dependent enhancement of HIV-1 infection be a problem with AIDS vaccines?
    Robinson WE; Montefiori DC; Mitchell WM
    Lancet; 1988 Apr; 1(8589):830-1. PubMed ID: 2895350
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection.
    Goudsmit J; Lange JM; Paul DA; Dawson GJ
    J Infect Dis; 1987 Mar; 155(3):558-60. PubMed ID: 3468176
    [No Abstract]   [Full Text] [Related]  

  • 3. The significance of HIV antigen and HIV antibodies specific against envelope and core proteins in serum of HIV-infected hemophiliacs.
    Rollag H; Evensen SA; Frøland SS; Glomstein A
    Eur J Haematol; 1987 Oct; 39(4):353-5. PubMed ID: 3480236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Another glitch for AIDS vaccines?
    Barnes DM
    Science; 1988 Jul; 241(4865):533-4. PubMed ID: 3399887
    [No Abstract]   [Full Text] [Related]  

  • 5. Specific antibody and virus antigen expression in congenital HIV infection.
    Tovo PA; Gabiano C; Riva C; Palomba E; Valpreda A; Musso A
    Lancet; 1987 May; 1(8543):1201. PubMed ID: 2883510
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein.
    Lasky LA; Groopman JE; Fennie CW; Benz PM; Capon DJ; Dowbenko DJ; Nakamura GR; Nunes WM; Renz ME; Berman PW
    Science; 1986 Jul; 233(4760):209-12. PubMed ID: 3014647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of HIV-Ag testing and anti-p24 titers in HIV carriers and AIDS patients.
    Roumeliotou A; Nestoridou E; Economidou I; Psarra E; Sidiri E; Choremi E; Kallinikos G; Papaevangelou G
    AIDS; 1988 Feb; 2(1):64. PubMed ID: 3129002
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prognostic significance of antibodies to HIV nuclear proteins in patients with the lymphadenopathy syndrome].
    Schulte C; Meurer M; Fröschl M
    Hautarzt; 1988 Jan; 39(1):45-8. PubMed ID: 3162727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal serologic evaluation of an infant with acquired immunodeficiency syndrome.
    Krilov LR; Kamani N; Hendry RM; Wittek AE; Quinnan GV
    Pediatr Infect Dis J; 1987 Nov; 6(11):1066-7. PubMed ID: 3480501
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunology of infection with the human immunodeficiency virus (HIV). A view from the III International Conference on AIDS.
    Koenig S; Rosenberg ZF
    Ann Intern Med; 1987 Sep; 107(3):409-11. PubMed ID: 3304052
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of HIV antigens in eluates from whole blood collected on filterpaper.
    Nielsen CM; Bygbjerg IC; Vestergaard BF
    Lancet; 1987 Mar; 1(8532):566-7. PubMed ID: 2881117
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediction of HIV vaccine.
    Robson B; Fishleigh RV; Morrison CA
    Nature; 1987 Jan 29-Feb 4; 325(6103):395. PubMed ID: 3468356
    [No Abstract]   [Full Text] [Related]  

  • 13. AIDS 1989. Vaccines and immunology: overview.
    Laurence J; Schild GC
    AIDS; 1989; 3 Suppl 1():S97-100. PubMed ID: 2514762
    [No Abstract]   [Full Text] [Related]  

  • 14. AIDS vaccine predictions.
    Barin F
    Nature; 1987 Jul 2-8; 328(6125):21. PubMed ID: 3474526
    [No Abstract]   [Full Text] [Related]  

  • 15. Human trials of AIDS vaccines: current status and future directions.
    Koff WC; Fauci AS
    AIDS; 1989; 3 Suppl 1():S125-9. PubMed ID: 2558684
    [No Abstract]   [Full Text] [Related]  

  • 16. [AIDS vaccines: an enigma in vaccine development].
    Dorner F; Barrett N
    Wien Klin Wochenschr; 1990 Jan; 102(2):51-8. PubMed ID: 1689919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of antibodies to the surface (anti-p-41) and nuclear protein (anti-p-24) of the human immunologic deficiency virus (HIV)].
    Hess G; Kroegel C; Ramadori G; Rieder H; Meyer zum Büschenfelde KH
    Med Klin (Munich); 1987 Oct; 82(21):723-5, 761. PubMed ID: 3500393
    [No Abstract]   [Full Text] [Related]  

  • 18. Human trials of experimental AIDS vaccines: recombinant envelope proteins.
    Snart RS
    AIDS; 1988; 2 Suppl 1():S107-11. PubMed ID: 2906544
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical importance of HIV antigen and anti-HIV core markers in persons infected with HIV.
    Lelie PN; Reesink HW; Bakker E; Huisman JG; ten Veen JH
    N Engl J Med; 1988 May; 318(18):1204-5. PubMed ID: 3163101
    [No Abstract]   [Full Text] [Related]  

  • 20. High prevalence of serum antibodies to reverse transcriptase in HIV-1-infected individuals.
    DeVico AL; Veronese FD; Lee SL; Gallo RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1988 Feb; 4(1):17-22. PubMed ID: 2452648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.